Glazer Capital LLC Takes $6.46 Million Position in Avanos Medical, Inc. $AVNS

Glazer Capital LLC acquired a new position in shares of Avanos Medical, Inc. (NYSE:AVNS) during the second quarter, Holdings Channel reports. The fund acquired 259,736 shares of the company’s stock, valued at approximately $6,462,000.

Several other large investors also recently made changes to their positions in AVNS. EverSource Wealth Advisors LLC raised its stake in Avanos Medical by 132.6% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,496 shares of the company’s stock worth $28,000 after buying an additional 1,423 shares during the period. Russell Investments Group Ltd. grew its stake in Avanos Medical by 969.3% in the second quarter. Russell Investments Group Ltd. now owns 2,545 shares of the company’s stock valued at $31,000 after acquiring an additional 2,307 shares during the period. Public Employees Retirement System of Ohio acquired a new stake in Avanos Medical in the second quarter valued at approximately $48,000. Wexford Capital LP bought a new stake in shares of Avanos Medical during the third quarter valued at approximately $70,000. Finally, Longfellow Investment Management Co. LLC bought a new stake in shares of Avanos Medical during the second quarter valued at approximately $75,000. 95.17% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Zacks Research upgraded Avanos Medical from a “strong sell” rating to a “hold” rating in a report on Friday, June 5th. Weiss Ratings restated a “sell (d-)” rating on shares of Avanos Medical in a report on Monday, July 20th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Avanos Medical has a consensus rating of “Reduce”.

Avanos Medical Price Performance

Shares of NYSE AVNS opened at $24.99 on Friday. The company has a market capitalization of $1.17 billion, a PE ratio of -15.52 and a beta of 1.57. The company has a quick ratio of 1.40, a current ratio of 2.48 and a debt-to-equity ratio of 0.11. The stock’s 50 day moving average price is $24.96 and its 200-day moving average price is $21.37. Avanos Medical, Inc. has a twelve month low of $9.30 and a twelve month high of $25.49.

Avanos Medical Profile

Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company’s products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.

In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.